Sector: Pharmaceuticals & Biotechnology

Mid Cap

Eris Lifesciences Share Price

Eris Lifesciences Ltd.

₹1,358

15.60(1.16%)

Invest in ERIS with up to 2.86x margin.

Trade with MTF

23rd Feb 2026 | 3:28 PM

NSE : ERIS

Open Free Demat Account

Eris Lifesciences Performance

Price Movement

₹1358.00

₹1327.00

₹1358.80

↘ Today's Low↗ Today's High

1 Year Performance

₹1358.00

₹1097.20

₹1910.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,358.80

Low₹1,327.00

Open at₹1,342.40

Prev Close₹1,342.40

Volumes78.83 K

Avg Price₹1,342.58

Lower Circuit₹1,074.00

Upper Circuit₹1,610.80

Historical Performance

3M High₹1,740.00

3M Low₹1,301.20

1 Yr High₹1,910.00

1 Yr Low₹1,097.20

3 Yr High₹1,910.00

3 Yr Low₹551.30

5 Yr High₹1,910.00

5 Yr Low₹473.50

Eris Lifesciences Fundamentals

Market Cap

High in industry

18,738 Cr.

PE Ratio (TTM)

Above industry Median

43.40

Dividend Yield

Net Profit TTM

31.1% incr over last year

431.74

Net Profit Growth

31.1% incr over last year

431.74

PEG Ratio

Above industry Median

1.40

ROE

19% decr over last year

12.32

Operating Revenue TTM

3,078.16

Operating Revenue Growth

12.5% incr over last year

Book Value

High in industry

6.10

MFI

MFI is mid-range

33.40

RSI

RSI is mid-range

40.75

EPS (TTM)

25.85

Debt to Equity

0.85

Face Value

Operating Profit Margin Qtr.

34.93

Operating Profit Qtr.

281.61

Net Profit Qtr.

99.72

Operating Revenue Qtr.

807.45

PB Ratio

6.10

Eris Lifesciences Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	315.29	650.50	578.64	404.77	399.73
Operating Expense	237.94	353.62	362.32	283.80	300.16
Operating Profit	77.35	296.88	216.32	120.97	99.57
Depreciation	38.66	39.30	37.60	43.38	46.68
Interest	45.20	46.50	45.14	53.16	54.65
Tax	0.80	85.10	56.27	10.71	4.25
Net Profit	3.09	149.57	99.99	30.47	1.78

ERIS Stock Recommendation by HDFC

View Call ↗

Research Type

Equity , Long Term

Buy Range

₹1,574 - ₹0

Target Price

₹1,810

Stop Loss

Target Date

13 Nov 26

Potential Returns

14.99 %

View Call ↗

Eris Lifesciences Technicals

Eris Lifesciences Ltd. EMA & SMA

₹1358.00

15.60 (1.16%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1354.1

Day EMA10 ₹1374

Day EMA12 ₹1379.7

Day EMA20 ₹1397.4

Day EMA26 ₹1409.3

Day EMA50 ₹1451.7

Day EMA100 ₹1507.3

Day EMA200 ₹1519.7

Eris Lifesciences Support and Resistance

Resistance

First Resistance₹1365.33

Second Resistance₹1377.97

Third Resistance₹1397.13

Support

First Support₹1333.53

Second Support₹1314.37

Third Support₹1301.73

Technical Indicators

Day RSI40.75

Day MFI33.40

Day ADX19.85

Day Commodity Channel Index-71.60

William-82.85

Day MACD-29.63

Day MACD Signal Line-23.79

Day ATR47.99

Day ROC125-23.52

Day ROC21-2.37

Eris Lifesciences Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	54.9	54.9	54.8	54.8	54.8	54.8
FII	8	8.4	8.4	8.4	7.2	6.8
DII	18.6	18	18.1	18.2	19.4	20.4
Public	18.5	18.7	18.6	18.6	18.6	18

Eris Lifesciences Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	19.93 K	36.48 K	54.63%
Week	44.29 K	74.6 K	59.37%
1 Month	42.43 K	76.58 K	55.41%
6 Month	62.39 K	1.27 L	49.07%

Eris Lifesciences SWOT Analysis

Strengths11

Weakness12

Opportunity10

Threats1

Positive Breakout First Resistance ( LTP > R1)

Benjamin Graham Value Screen

Consistent high performing stocks over Five Years

Mid-range Performer (DVM)

Rising Net Cash Flow and Cash from Operating activity

PEG lower than Industry PEG

Increasing Revenue every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Book Value per share Improving for last 2 years

Top Gainers

Eris Lifesciences Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
13 Feb, 2025	7.35	INTERIM	13 Feb, 2025	Equity Share
11 Aug, 2022	7.35	INTERIM	16 Aug, 2022	Equity Share
05 Aug, 2021	6.01	INTERIM	06 Aug, 2021	Equity Share
13 Aug, 2020	5.5	INTERIM	14 Aug, 2020	Equity Share
19 Mar, 2020	2.87	INTERIM	20 Mar, 2020	Equity Share

Eris Lifesciences Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Rubicon Research Ltd.	Sai Life Science Ltd.	OneSource Specialty Pharma Ltd.	Sanofi Consumer Healthcare India Ltd.
Price (₹)	₹1,577	₹628.95	₹780	₹968	₹1,320	₹4,075
% Change	3.47%	-5.40%	-0.01%	2.83%	3.96%	0.75%
Revenue TTM (₹ Cr)	-	-	₹1,598.19	₹2,169.86	₹1,419.33	₹798.10
Net Profit TTM (₹ Cr)	-	-	₹206.20	₹332.94	₹20.10	₹217.90
PE TTM	-	-	62.20	61.50	754.90	43.10
1 Year Return	48.29	6.51	60.63	37.17	3.9	-12.48
ROCE	30.24	34.78	34.76	12.51	3.26	-

Similar Stocks

AKUMS

Akums Drugs & Pharmaceuticals Ltd.

₹ 474.00

-0.91%

BLUEJET

Blue Jet Healthcare Ltd

₹ 391.40

+9.99%

CONCORDBIO

Concord Biotech Ltd.

₹ 1103.00

+0.46%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 687.60

-1.60%

SUPRIYA

Supriya Lifescience Ltd.

₹ 670.00

-1.17%

ACUTAAS

Acutaas Chemicals Ltd.

₹ 2138.50

+1.52%

ALIVUS

Alivus Life Sciences Ltd.

₹ 901.15

-1.08%

COHANCE

Cohance Lifesciences Ltd.

₹ 315.10

+3.18%

SYNGENE

Syngene International Ltd.

₹ 448.60

+1.33%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 774.90

+1.55%

STAR

Strides Pharma Science Ltd.

₹ 872.90

+0.37%

GRANULES

Granules India Ltd.

₹ 598.00

-0.18%

FDC

FDC Ltd.

₹ 383.00

+3.82%

SHILPAMED

Shilpa Medicare Ltd.

₹ 329.00

+1.29%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 900.00

+3.15%

NATCOPHARM

Natco Pharma Ltd.

₹ 886.00

-0.64%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 1739.00

+2.77%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 13507.00

+6.88%

MARKSANS

Marksans Pharma Ltd.

₹ 179.32

+0.53%

SANOFI

Sanofi India Ltd.

₹ 4080.00

+1.34%

PGHL

Procter & Gamble Health Ltd.

₹ 5080.00

+1.21%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 674.90

-2.16%

FAQ's on ERIS

What is the current share price of Eris Lifesciences Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Eris Lifesciences Ltd. is ₹ 1358 on the NSE and ₹ 1355.8 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Eris Lifesciences Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Eris Lifesciences Ltd. is approximately ₹ 18738 Cr.

What are the PE and PB ratios for Eris Lifesciences Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Eris Lifesciences Ltd. is 43.4, and the Price-to-Book (PB) ratio is 6.1.

What is the 52-Week High and Low for Eris Lifesciences Ltd.?

Over the past 52 weeks, the highest price reached by Eris Lifesciences Ltd. shares was ₹ 1910, and the lowest price was ₹ 1097.2.

Who are the major shareholders of Eris Lifesciences Ltd.?

Significant shareholdings in Eris Lifesciences Ltd. typically include entities such as:

Promoter
Mutual Funds
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Eris Lifesciences Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Eris Lifesciences Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

What is the latest dividend information for Eris Lifesciences Ltd.?

Eris Lifesciences Ltd. last declared a INTERIM dividend of ₹ 7.35 per share for the financial period ending 2025. The record date was set as 2025-02-13, and the payment was/is scheduled around 2025-02-13. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy